The Chemours Company
CC
$20.22
-$0.64-3.07%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.83% | -11.04% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.83% | -11.04% | |||
| Cost of Revenue | -0.17% | -7.06% | |||
| Gross Profit | 33.33% | -32.34% | |||
| SG&A Expenses | 38.10% | 0.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.84% | -6.33% | |||
| Operating Income | 51.85% | -74.04% | |||
| Income Before Tax | 67.16% | -231.37% | |||
| Income Tax Expenses | 240.00% | 44.44% | |||
| Earnings from Continuing Operations | 53.23% | -203.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 52.46% | -201.67% | |||
| EBIT | 51.85% | -74.04% | |||
| EBITDA | -8.40% | -28.42% | |||
| EPS Basic | 53.13% | -201.58% | |||
| Normalized Basic EPS | 100.00% | -162.72% | |||
| EPS Diluted | 53.71% | -202.86% | |||
| Normalized Diluted EPS | 100.00% | -162.90% | |||
| Average Basic Shares Outstanding | 1.44% | 0.10% | |||
| Average Diluted Shares Outstanding | 1.44% | -0.21% | |||
| Dividend Per Share | -- | 0.00% | |||
| Payout Ratio | -0.82% | -2.13% | |||